PIA
ABEO icon

Piedmont Investment Advisors’s Abeona Therapeutics ABEO Stock Holding History

Piedmont Investment Advisors’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-21
Closed -$9K – 1040
2018
Q2 		$9K Buy
+21
New +$9.18K ﹤0.01% 1852

Other funds holding ABEO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

Piedmont Investment Advisors's ABEO Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Abeona Therapeutics (ABEO) in Q3 2018, closing a stake of 21 shares — an estimated $9K sold.

Piedmont Investment Advisors first reported a position in ABEO in Q2 2018 and held it in 1 quarter. The position peaked at $9K in Q2 2018. 104 funds tracked by Wall St. Rank hold ABEO as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Abeona Therapeutics position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 21 Abeona Therapeutics shares in Q3 2018, an estimated $9K.
  • Piedmont Investment Advisors first reported a position in Abeona Therapeutics in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Abeona Therapeutics position peaked at $9K in Q2 2018.
  • 104 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.